Product Information

INSULIN GLARGINE SOLOSTAR U300 is a generic product labeled by Sanofi-Aventis U.S. LLC, priced at $27.0216 per ML under NDC 00955390003. Its NADAC has been published 110 times since Apr 17, 2024.

INSULIN GLARGINE SOLOSTAR U300

insulin glargine
$27.0216per ML

Strength

300 [iU]/mL

NDC

00955390003

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

INSULIN GLARGINE

Approval Type

Biologic (BLA)

FDA Application

BLA206538

On Market Since

4/1/2023

Pharmacological Classes

Price Statistics

The NADAC for INSULIN GLARGINE SOLOSTAR U300 has been published 110 times since Apr 17, 2024, and over the history we have for it it has declined 26.6%. The table below summarizes its recorded NADAC range and movement.

Current price$27.0216 per ML
All-time high$36.8236 (May 15, 2024)
All-time low$26.9353 (Apr 22, 2026)
52-week high$36.7049
52-week low$26.9353
Median price$36.6337
Average price$35.0731
Largest weekly change-26.4% (Apr 22, 2026)
Weeks tracked110
Tracking sinceApr 17, 2024

Price History

1W

-0.1%

1M

-0.1%

3M

+0.1%

6M

-26.1%

1Y

-26.3%

3Y

N/A

5Y

N/A

All

-26.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of INSULIN GLARGINE SOLOSTAR U300?

The current National Average Drug Acquisition Cost (NADAC) for INSULIN GLARGINE SOLOSTAR U300, manufactured by Sanofi-Aventis U.S. LLC, is $27.0216 per ML (NDC 00955390003), effective Aug 19, 2026.

How has the price of INSULIN GLARGINE SOLOSTAR U300 changed over time?

Over the history we have for it, the NADAC for INSULIN GLARGINE SOLOSTAR U300 has declined 26.6%. It has been tracked across 110 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for INSULIN GLARGINE SOLOSTAR U300?

Since Apr 17, 2024, the NADAC for INSULIN GLARGINE SOLOSTAR U300 has ranged from a low of $26.9353 (Apr 22, 2026) to a high of $36.8236 (May 15, 2024), with a median of $36.6337 per ML.

Are there cheaper alternatives to INSULIN GLARGINE SOLOSTAR U300?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INSULIN GLARGINE MAX SOLO U300, is $27.0143 per ML — about 0% below INSULIN GLARGINE SOLOSTAR U300.

Who manufactures INSULIN GLARGINE SOLOSTAR U300?

INSULIN GLARGINE SOLOSTAR U300 (NDC 00955390003) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a generic product.